Prognostication of Upper Tract Urothelial Carcinoma: What Do We Really Need?

European Urology

Volumn 57, Issue 4, 2010, Pages 582-583

  Dalbagni, Guido ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; EDITORIAL; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; NEPHROURETERECTOMY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; RISK REDUCTION; SURVIVAL RATE; TREATMENT RESPONSE; TUMOR NECROSIS; URINARY TRACT CARCINOMA;

CARCINOMA; CHEMOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NECROSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS; UROTHELIUM;

EID: 77249149867     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.11.045     Document Type: Editorial

References (11)

1. Zigeuner R., Shariat S.F., Margulis V., et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol 57 (2010) 575-581
2. Kwak C., Lee S.E., Jeong I.G., et al. Adjuvant systemic chemotherapy in the treatment of patients with invasive transitional cell carcinoma of the upper urinary tract. Urology 68 (2006) 53-57
3. Lee S.E., Byun S.S., Park Y.H., et al. Adjuvant chemotherapy in the management of pt3n0m0 transitional cell carcinoma of the upper urinary tract. Urol Int 77 (2006) 22-26
4. Hellenthal N.J., Shariat S.F., Margulis V., et al. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the upper tract urothelial carcinoma collaboration. J Urol 182 (2009) 900-906
5. Kim H.L., Shah S.K., Tan W., et al. Estimation and prediction of renal function in patients with renal tumor. J Urol 181 (2009) 2451-2460 discussion 2460-1
6. O'Malley R., Kaag M., O'Malley P., et al. Do changes in renal function following nephroureterectomy impact the use of perioperative chemotherapy?. J Urol 181 Suppl (2009) 136
7. Grossman H.B., Natale R.B., Tangen C.M., et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349 (2003) 859-866
8. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data. Eur Urol 2005; 48:189-201, discussion 199-201.
9. Igawa M., Urakami S., Shiina H., et al. Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract. Urol Int 55 (1995) 74-77
10. Olgac S., Mazumdar M., Dalbagni G., et al. Urothelial carcinoma of the renal pelvis: a clinicopathologic study of 130 cases. Am J Surg Pathol 28 (2004) 1545-1552
11. Brown G.A., Matin S.F., Busby J.E., et al. Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy. Urology 70 (2007) 252-256